Brand-name, generics firms fight over bulk drug supplies

11/11/2009 | Wall Street Journal, The

Complaints from generic-drug firms prompted the Federal Trade Commission to look into practices of brand-name companies that refuse to supply bulk quantities of medicines that can aid the development of copycat drugs. The FTC did not say whether it is investigating. Meanwhile, Dr. Reddy's Laboratories filed a petition with the FDA to clarify whether brand-name manufacturers can hide behind a drug-safety program that restricts the distribution of certain treatments to prevent misuse.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA